Immunodiagnostics Market Overview
Immunodiagnostics market is expected to garner $17,836 Million by 2022, registering a CAGR of 7.3% during the forecast period 2016-2022. Immunodiagnostics is the branch of in vitro diagnostics that deals with the diagnosis of several diseases on the basis of antigen antibody reaction. Its a primary means for diagnosing infectious disease, chronic diseases such as cancer and cardiovascular diseases, autoimmunity diseases, and endocrinology among others. The significant advancement in the immunodiagnostics technologies have enhanced the ability to target the areas to diagnose disease progression. The growth in development has improved the diagnosis of complex diseases. The immunodiagnostics market is segmented based on product type into reagents, instruments, and software & services. The infectious diseases holds a remarkable share in the global immunodiagnostics market and is expected to maintain its lead during the study period. This is attributed by the growth in preference of automated and next generation immunodiagnostics platform due to accurate, rapid and reliable outcomes and increased adoption by the clinicians.
Global Immunodiagnostics Market Segmentation
The rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases across the world owing to the growth in aged population and changes in demographics & lifestyle are the major factors to drive the growth of the immunodiagnostics market. In addition, technological advancement in diagnosis kits, assays and analyzers and increase in awareness of the preventive health measures among the patients and medical professionals further stimulate the demand for immunodiagnostics products thus boosting the growth. However, numerous factors are expected to restrain the market development. The impact of the drivers is estimated to be higher than the restraints. Moreover, an increase in effect of the drivers and the restraints is anticipated to reveal new market opportunities for key players manufacturing immunodiagnostics products especially the kits and assays.
Key Drivers and Restraints of Immunodiagnostics market
Global Immunodiagnostics Market, By End User, 2014-2022 ($Million)
Pathologists generally operate independently and have tie ups and collaborations with some hospital or clinics. The demand for the immunodiagnostic analysis has led to the increased profits of these laboratories. Laboratory test includes the examinations for infectious and viral diseases, such as HIV, hepatitis, dengue, and chikungunya. Different laboratory tests are also designed to execute routine blood tests for anemia, autoimmune diseases, and others. Various devices are available to test, classify, and diagnose diseases such as the immunoglobulin test, rheumatoid factor tests, and Human Leukocyte Typing (HLA typing) tests.
The immunodiagnostics tests can be performed in various hospital departments, such as serological labs, pathological labs, clinical microbiology departments, histopathology and hematology sections, clinical biochemistry laboratories, and hospital wards. However, complex as well as the simple tests can be performed in hospitals. Some of the immunodiagnostics instruments give quick results and in case of complex tests, the sample is sent to the concerned laboratories. Various tests in hospitals include, Enzyme-Linked Immunosorbent Assay, western blot, infectious tests, and other immunological assays.
Academic and Research centers
Trainings provided in academic and research centers and medical colleges in the form of internships and training sessions. These training and education services comprise a large market for immunodiagnostics. The training in these centers is carried out with the help of different instruments such as flow cytometer and HPLC. The increased use of these instruments has surged the demand for these equipment worldwide. Proper training for usage of immunodiagnostics products such as, kits, assays, and analyzers, their maintenance, and disposal is given through these educational services. Some of the universities also provide online trainings for the use of immunodiagnostics.
Pharmaceutical and Biotechnology Industry
Biotechnology deals with the employment of natural based material, plant material, organisms, and natural processes to design and produce products that are overall beneficial and improve the quality of human life. Different substances for instance, biomolecules such as proteins can act as immunodiagnostic agents to execute significant immunodiagnostic processes. After clinical laboratories and hospitals, the pharmaceutical and biotechnology industries are the traditional strongholds of the immunodiagnostic market. Immunodiagnostic kits are widely used by druggists to monitor drug delivery and the effect of the drugs administered in the system.
Immunodiagnostics has various other end users such as contract research organizations (CROs), blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical services and centers.
Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc. are the key players that operate in the global immunodiagnostics market.
Other players in the value chain include Arkray, Inc., Alere, Inc., Merck Millipore, Becton, Dickinson and Company, Biomerieux SA, Medicaroid Corporation, Qiagen NV, Affimetrix, ImmunoDX, Meridian Bioscience and others
IMMUNODIAGNOSTICS MARKET KEY BENEFITS
- The study provides an in-depth analysis of the global immunodiagnostics market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
- Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
- Porters Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.
- Extensive analysis is conducted by following key product positioning and monitoring the top competitors within the market framework.
IMMUNODIAGNOSTICS MARKET KEY SEGMENTS
- Software & Services
- Enzyme-Linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Fluorescent Immunoassay
- Rapid Test
- Infectious diseases
- Oncology & endocrinology
- Hepatitis & retrovirus
- Bone & mineral
- Cardiac biomarker
By End User
- Clinical laboratories
- Academic & Research Centers
- Pharmaceutical & Biotechnology Industry
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Middle East